Let’s start up with the current stock price of Ampio Pharmaceuticals Inc. (AMPE), which is $2.16 to be very precise. The Stock rose vividly during the last session to $2.41 after opening rate of $2.41 while the lowest price it went was recorded $2.11 before closing at $2.27.
Recently in News on February 1, 2021, Ampio Announces Early Positive Data in Phase 1 Trial of Inhaled Ampion in COVID-19 Respiratory Distress. – Subjects who received Ampion treatment required less oxygen than standard of care alone. You can read further details here
Ampio Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.44 on 02/10/21, with the lowest value was $1.29 for the same time period, recorded on 01/15/21.
Ampio Pharmaceuticals Inc. (AMPE) full year performance was 242.80%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Ampio Pharmaceuticals Inc. shares are logging -27.52% during the 52-week period from high price, and 596.77% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.31 and $2.98.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3853673 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Ampio Pharmaceuticals Inc. (AMPE) recorded performance in the market was 35.85%, having the revenues showcasing 174.81% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 397.72M, as it employees total of 23 workers.
Ampio Pharmaceuticals Inc. (AMPE) in the eye of market guru’s
During the last month, 0 analysts gave the Ampio Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.24, with a change in the price was noted +1.22. In a similar fashion, Ampio Pharmaceuticals Inc. posted a movement of +129.45% for the period of last 100 days, recording 5,255,310 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for AMPE is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Ampio Pharmaceuticals Inc. (AMPE): Stocks Technical analysis and Trends
Raw Stochastic average of Ampio Pharmaceuticals Inc. in the period of last 50 days is set at 60.75%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 75.65%. In the last 20 days, the company’s Stochastic %K was 84.39% and its Stochastic %D was recorded 88.87%.
If we look into the earlier routines of Ampio Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 35.85%. Additionally, trading for the stock in the period of the last six months notably improved by 168.96%, alongside a boost of 242.80% for the period of the last 12 months. The shares increased approximately by 10.77% in the 7-day charts and went down by 51.05% in the period of the last 30 days. Common stock shares were driven by 174.81% during last recorded quarter.